Big Tobacco, Alcohol, and Pharma Companies Are Moving Into the Cannabis Industry

All five cannabis companies (Canopy Growth, Aurora, Tilray, Cronos Group, Organigram) had investment relationships with alcohol, tobacco, or pharmaceutical companies. Some received substantial investments that came with industry influence. Employee flows showed cross-industry expertise transfer, particularly in management, finance, and strategy, suggesting established industries are strategically positioning themselves in the cannabis sector.

Exploratory multi-case study analyzing business investments and employee movement between five cannabis companies and alcohol, tobacco, and pharmaceutical companies. Data from Nexis Uni, corporate reports, press releases, and LinkedIn.

The alcohol and tobacco industries have well-documented histories of marketing to vulnerable populations, lobbying against regulations, and prioritizing profits over public health. Their entry into cannabis markets raises concerns about importing these practices.

Cannabis commercialization is at a critical juncture. The industry connections documented here mirror historical patterns where established consumer product companies have entered new markets and shaped regulation in their favor, often at the expense of public health.

Exploratory study focused on only five companies. Publicly available data may not capture all relationships. Cannot prove that cross-industry connections have actually harmed public health. Canadian/North American focus may not apply to other markets.